title: Interleukin-8 secretion and 15-lipoxygenase activity in rheumatoid arthritis: in vitro anti-inflammatory effects by interleukin-4 and interleukin-10, but not by interleukin-1 receptor antagonist protein.
abstract: We have examined the ability of interleukin-4 (IL-4), interleukin-10 (IL-10) and interleukin-1 receptor antagonist protein (IL-1ra) to regulate spontaneous interleukin-8 (IL-8) production in cultured SF mononuclear cells (SFMC) from RA. Furthermore, we examined whether IL-4, IL-10, or IL-1ra could influence the production of the arachidonic acid products leukotriene B4 (LTB4), 12-hydroxy-eicosatetraenoic acid (12-HETE) and 15-hydroxy-eicosatetraenoic acid (15-HETE). IL-4 induced a maximal suppression of 75% in the IL-8 secretion in SFMC from 10.0 ng/ml down to 2.5 ng/ml after 24 h and from 17.2 ng/ml to 4.2 ng/ml after 72 h of culture. IL-10 induced a 55% inhibition of the IL-8 secretion at 24 h and a 40% inhibition at 72 h. IL-1ra did not change the spontaneous IL-8 secretion from rheumatoid SFMC. We also examined, whether addition of IL-4, IL-10 or IL-1ra was able to modulate formation of the arachidonic acid products LTB4, 12-HETE and 15-HETE in cultured SF cells, stimulated with the calcium ionophore A23187. 15-HETE was not detected in untreated cultures, nor in IL-10 or IL-1ra treated cultures. IL-4, however, stimulated the formation of the anti-inflammatory mediator; 15-HETE (23 ng/10(6) cells). These results suggest that IL-4 or IL-10, could have beneficial anti-inflammatory effects in RA.
authors.affiliation: Department of Rheumatology, University Hospital of Aarhus, Denmark.
authors.forename: B
authors.initials: B
authors.lastname: Deleuran
authors.forename: L
authors.initials: L
authors.lastname: Iversen
authors.forename: M
authors.initials: M
authors.lastname: Kristensen
authors.forename: M
authors.initials: M
authors.lastname: Field
authors.forename: K
authors.initials: K
authors.lastname: Kragballe
authors.forename: K
authors.initials: K
authors.lastname: Thestrup-Pedersen
authors.forename: K
authors.initials: K
authors.lastname: Stengaard-Pedersen
mesh_terms: D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; D001172:Arthritis, Rheumatoid / Q000378:metabolism*; D006801:Humans; D006893:Hydroxyeicosatetraenoic Acids / Q000378:metabolism*; D053590:Interleukin 1 Receptor Antagonist Protein; D016753:Interleukin-10 / Q000494:pharmacology*; D015847:Interleukin-4 / Q000494:pharmacology*; D016209:Interleukin-8 / Q000378:metabolism*; D007975:Leukotriene B4 / Q000378:metabolism; D012795:Sialoglycoproteins / Q000494:pharmacology*; D013582:Synovial Fluid / Q000166:cytology / Q000378:metabolism
chemical_list: D006893:Hydroxyeicosatetraenoic Acids; C507763:IL1RN protein, human; D053590:Interleukin 1 Receptor Antagonist Protein; D016209:Interleukin-8; D012795:Sialoglycoproteins; D016753:Interleukin-10; D007975:Leukotriene B4; D015847:Interleukin-4; D019377:12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; C025984:15-hydroxy-5,8,11,13-eicosatetraenoic acid